InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,522.30
(
1.58%
)
US TECH 100
19,006.40
(
3.85%
)
Dow Jones
40,842.79
(
0.24%
)
Brent Oil
81.51
(
3.75%
)
Bitcoin
64,751.96
(
-2.14%
)
Post# of 13742
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

SC777

Send PM Follow Ignore
Followers 139
Posts 17860
Boards Moderated 0
Alias Born 03/08/2015

SC777

Re: halbroke1 post# 2580

Wednesday, 05/12/2021 9:16:55 PM

Wednesday, May 12, 2021 9:16:55 PM

Post# of 13742
The FDA approval is for Escozine as a COVID therapeutic.


“Medolife Rx, an integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic.”
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up